[go: up one dir, main page]

EA200601771A1 - Система, задерживающаяся в желудке - Google Patents

Система, задерживающаяся в желудке

Info

Publication number
EA200601771A1
EA200601771A1 EA200601771A EA200601771A EA200601771A1 EA 200601771 A1 EA200601771 A1 EA 200601771A1 EA 200601771 A EA200601771 A EA 200601771A EA 200601771 A EA200601771 A EA 200601771A EA 200601771 A1 EA200601771 A1 EA 200601771A1
Authority
EA
Eurasian Patent Office
Prior art keywords
stomach
tensile
system delayed
delayed
lingering
Prior art date
Application number
EA200601771A
Other languages
English (en)
Other versions
EA011151B1 (ru
Inventor
Нитин Бхалачандра Дхармадхикари
Яшорадж Рупсинх Зала
Original Assignee
Сан Фармацевтикал Индастрис Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Сан Фармацевтикал Индастрис Лимитед filed Critical Сан Фармацевтикал Индастрис Лимитед
Publication of EA200601771A1 publication Critical patent/EA200601771A1/ru
Publication of EA011151B1 publication Critical patent/EA011151B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices ; Anti-rape devices
    • A61F5/0003—Apparatus for the treatment of obesity; Anti-eating devices
    • A61F5/0013—Implantable devices or invasive measures
    • A61F5/003—Implantable devices or invasive measures inflatable
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices ; Anti-rape devices
    • A61F5/0003—Apparatus for the treatment of obesity; Anti-eating devices
    • A61F5/0013—Implantable devices or invasive measures
    • A61F5/0036—Intragastrical devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Nursing (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Данное изобретение предлагает новую систему, задерживающуюся в желудке, в форме таблетки или капсулы, покрытой растяжимой оболочкой, в частности растяжимой оболочкой, содержащей полимер, образующий пленку и растяжимый компонент.
EA200601771A 2004-03-25 2005-03-24 Система, задерживающаяся в желудке EA011151B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN364MU2004 2004-03-25
IN1058MU2004 2004-10-07
PCT/IN2005/000091 WO2005101983A2 (en) 2004-03-25 2005-03-24 Gastric retention system

Publications (2)

Publication Number Publication Date
EA200601771A1 true EA200601771A1 (ru) 2007-02-27
EA011151B1 EA011151B1 (ru) 2009-02-27

Family

ID=35197425

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200601771A EA011151B1 (ru) 2004-03-25 2005-03-24 Система, задерживающаяся в желудке

Country Status (21)

Country Link
US (1) US9439851B2 (ru)
EP (1) EP1732522B1 (ru)
JP (1) JP5166018B2 (ru)
KR (1) KR101147666B1 (ru)
CN (1) CN1960711A (ru)
AP (1) AP2006003751A0 (ru)
AR (1) AR048331A1 (ru)
AU (1) AU2005235239B2 (ru)
BR (1) BRPI0508744A (ru)
CA (1) CA2561109C (ru)
EA (1) EA011151B1 (ru)
ES (1) ES2389729T3 (ru)
IL (1) IL178054A (ru)
MA (1) MA28542B1 (ru)
MX (1) MXPA06010678A (ru)
MY (1) MY148867A (ru)
NZ (1) NZ549853A (ru)
PE (1) PE20061160A1 (ru)
PL (1) PL1732522T3 (ru)
TW (1) TW200533391A (ru)
WO (1) WO2005101983A2 (ru)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7699863B2 (en) 2005-03-01 2010-04-20 Tulip Medical Ltd. Bioerodible self-deployable intragastric implants
US7785291B2 (en) 2005-03-01 2010-08-31 Tulip Medical Ltd. Bioerodible self-deployable intragastric implants
NZ566642A (en) * 2005-08-30 2011-11-25 Piramal Life Sciences Ltd Extended release pharmaceutical composition of metformin and a process for producing it
US7674396B2 (en) * 2005-11-08 2010-03-09 Plensat Llc Method and system for treatment of eating disorders
AU2007201808B8 (en) 2006-04-26 2013-09-05 Sun Pharmaceutical Advanced Research Company Ltd A method for alleviating signs and symptoms of spasticity
EP2032093B1 (en) 2006-05-18 2013-09-04 Tulip Medical Ltd. Bioerodible intragastric implant
US8765178B2 (en) 2006-07-19 2014-07-01 Watson Laboratories, Inc. Controlled release formulations and associated methods
WO2008039186A2 (en) * 2006-09-26 2008-04-03 Plensat, Llc Method and system for treatment of eating disorders
CA2673111A1 (en) * 2006-12-07 2008-06-19 Schering Corporation Ph sensitive matrix formulation
KR20080076382A (ko) * 2007-02-15 2008-08-20 (주)아모레퍼시픽 실로스타졸의 제어방출 제제 및 그 제조방법
US20090028941A1 (en) * 2007-07-27 2009-01-29 Depomed, Inc. Pulsatile gastric retentive dosage forms
MX2010001629A (es) * 2007-08-10 2010-08-09 Alessandro Sannino Hidrogeles de polimero y metodos de preparacion de los mismos.
US20110171275A1 (en) * 2007-08-20 2011-07-14 Team Academy Of Pharmaceutical Science Gastroretentive drug delivery system, preparation method and use thereof
AU2009281752B2 (en) * 2008-08-15 2016-11-17 Depomed Inc. Gastric retentive pharmaceutical compositions for treatment and prevention of CNS disorders
KR20110042366A (ko) * 2008-08-18 2011-04-26 팀 아카데미 오브 파마슈티컬 사이언스 위장체류 약물 전달 시스템, 제작 방법 및 그것들의 사용
FR2938431B1 (fr) 2008-11-14 2013-12-20 Debregeas Et Associes Pharma Nouvelle composition a base d'acide gamma-hydroxybutyrique
FR2949061B1 (fr) * 2009-08-12 2013-04-19 Debregeas Et Associes Pharma Microgranules flottants
FR2949062B1 (fr) 2009-08-12 2011-09-02 Debregeas Et Associes Pharma Nouvelles formulations pharmaceutiques contre le mesusage des medicaments
CA2790164A1 (en) 2010-02-17 2011-08-25 Sun Pharma Advanced Research Company Ltd. Method of treating a disease condition susceptible to baclofen therapy
EP2389933A1 (en) * 2010-05-25 2011-11-30 Sanovel Ilac Sanayi ve Ticaret A.S. Controlled-Release Pregabalin Compositions
BR112013003581B8 (pt) 2010-08-18 2022-07-05 Evonik Roehm Gmbh Composição farmacêutica ou nutracêutica gastro resistente, que compreende um ou mais sais do ácido algínico, e seu processo de produção
US8808740B2 (en) 2010-12-22 2014-08-19 Purdue Pharma L.P. Encased tamper resistant controlled release dosage forms
PH12013501345A1 (en) 2010-12-23 2022-10-24 Purdue Pharma Lp Tamper resistant solid oral dosage forms
US20130017264A1 (en) * 2011-07-15 2013-01-17 Piramal Life Sciences Limited Alginate tube drug delivery system and method therefor
US10137094B2 (en) * 2011-10-11 2018-11-27 Sun Pharmaceutical Industries Limited Gastroretentive dosage system and process of preparation thereof
US10507127B2 (en) 2012-06-07 2019-12-17 Epitomee Medical Ltd. Expandable device
HUE031818T2 (en) * 2012-08-27 2017-08-28 Evonik Roehm Gmbh A stomach-resistant medical or nutritional preparation that is resistant to ethanol
HK1207822A1 (en) 2012-08-27 2016-02-12 Evonik Röhm Gmbh Pharmaceutical or nutraceutical composition with sustained release characteristic and with resistance against the influence of ethanol
PE20151301A1 (es) 2013-02-05 2015-09-16 Purdue Pharma Lp Formulaciones farmaceuticas resistentes a la manipulacion indebida
US10751287B2 (en) 2013-03-15 2020-08-25 Purdue Pharma L.P. Tamper resistant pharmaceutical formulations
AU2014358675B2 (en) * 2013-12-05 2019-10-03 Epitomee Medical Ltd Retentive devices and systems for in-situ release of pharmaceutical active agents
MX358196B (es) * 2014-02-17 2018-08-08 Evonik Roehm Gmbh Composicion farmaceutica o nutraceutica con caracteristica de liberacion sostenida y con resistencia contra la influencia del etanol.
KR101642193B1 (ko) * 2014-10-13 2016-07-25 씨제이헬스케어 주식회사 메트포르민 서방성 제제 및 그의 제조방법
EP3025709B1 (en) 2014-11-27 2020-09-30 Capsugel Belgium NV Dosage form articles for external mucosal applications
CN107708677B (zh) 2015-06-05 2021-07-13 赢创运营有限公司 耐乙醇影响的药物或保健品组合物
EP3167879A1 (en) 2015-11-10 2017-05-17 Evonik Technochemie GmbH Gastric retention active delivery systems
US10737079B2 (en) * 2016-12-02 2020-08-11 Clexio Biosciences Ltd. Gastric residence system
IL250090B (en) 2017-01-12 2018-10-31 Melcap Systems Ltd A capsule is intended for ingestion by a subject and a system is intended for the digestive system
EP3600320A4 (en) 2017-03-31 2020-12-16 Acura Pharmaceuticals, Inc. METHODS AND COMPOSITIONS FOR THE SELF-REGULATED RELEASE OF ACTIVE PHARMACEUTICAL SUBSTANCES
JP6823539B2 (ja) * 2017-05-26 2021-02-03 株式会社ファンケル 胃内滞留性錠剤
US10987311B2 (en) 2017-06-16 2021-04-27 Kashiv Specialty Pharmaceuticals, Llc Extended release compositions comprising pyridostigmine
US10588863B2 (en) 2017-06-16 2020-03-17 Kashiv Biosciences, Llc Extended release compositions comprising pyridostigmine
ES2928071T3 (es) 2017-06-16 2022-11-15 Amneal Complex Products Res Llc Formas de dosificación gastrorretentiva para el suministro sostenido de fármacos
FR3068039B1 (fr) 2017-06-22 2020-07-10 Jellynov Composition auto-moussante en milieu acide et procede de preparation
US10918511B2 (en) 2017-07-26 2021-02-16 Verily Life Sciences Llc Ingestible intragastric balloon
CA3085941A1 (en) 2017-12-18 2019-06-27 Tris Pharma, Inc. Ghb pharmaceutical compositions comprising a floating interpenetrating polymer network forming system
WO2019126214A1 (en) 2017-12-18 2019-06-27 Tris Pharma, Inc. Pharmaceutical composition comprising ghb gastro-retentive raft forming systems having trigger pulse drug release
AU2018388577B2 (en) 2017-12-18 2024-06-06 Tris Pharma, Inc. Modified release drug powder composition comprising gastro-retentive raft forming systems having trigger pulse drug release
CN111405895B (zh) * 2017-12-29 2022-10-21 江苏恒瑞医药股份有限公司 一种控释药物组合物及其制备方法
EP3797818B1 (en) 2018-05-23 2023-01-18 Shanghai WD Pharmaceutical Co., Ltd Controlled-release system of active pharmaceutical ingredient and preparation method therefor
CN114191307A (zh) 2020-09-17 2022-03-18 上海汉都医药科技有限公司 一种口腔滞留装置及其制备方法
US11911513B2 (en) 2018-05-23 2024-02-27 Shanghai Wd Pharmaceutical Co., Ltd Controlled-release system of active pharmaceutical ingredient and preparation method therefor
ES2861153T3 (es) 2018-06-18 2021-10-05 Composiciones de liberación prolongada que comprenden piridostigmina
FR3089224B1 (fr) * 2018-12-04 2020-12-11 Jellynov Composition auto-moussante en milieu acide et procédé de préparation
WO2020230089A1 (en) 2019-05-14 2020-11-19 Clexio Biosciences Ltd. Treatment of nocturnal symptoms and morning akinesia in subjects with parkinson's disease
CN113116845B (zh) * 2019-12-31 2024-03-19 广州玻思韬控释药业有限公司 胃滞留片
WO2022195476A1 (en) 2021-03-15 2022-09-22 Clexio Biosciences Ltd. Gastroretentive devices for assessment of intragastric conditions

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3786813A (en) 1972-12-27 1974-01-22 Alza Corp Drug delivery device with self actuated mechanism for retaining device in selected area
US4207890A (en) 1977-01-04 1980-06-17 Mcneilab, Inc. Drug-dispensing device and method
US4101650A (en) 1977-04-06 1978-07-18 Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai Pepstatin floating minicapsules
EP0205336B1 (en) 1985-06-11 1991-09-11 Teijin Limited Oral sustained release pharmaceutical preparation
JPS62195323A (ja) 1986-02-24 1987-08-28 Eisai Co Ltd 胃内滞留型粒子
JPH0747534B2 (ja) 1986-06-02 1995-05-24 ロ−ラ−ジヤパン株式会社 錠 剤
IL87710A (en) 1987-09-18 1992-06-21 Ciba Geigy Ag Covered floating retard form for controlled release in gastric juice
GB8722306D0 (en) * 1987-09-22 1987-10-28 Aps Research Ltd Sustained-release formulation
IT1245890B (it) * 1991-04-12 1994-10-25 Alfa Wassermann Spa Formulazioni farmaceutiche per uso orale gastroresistenti contenenti acidi biliari.
DE4406424A1 (de) 1994-02-28 1995-08-31 Bayer Ag Expandierbare Arzneiformen
SE9600070D0 (sv) * 1996-01-08 1996-01-08 Astra Ab New oral pharmaceutical dosage forms
US5783212A (en) 1996-02-02 1998-07-21 Temple University--of the Commonwealth System of Higher Education Controlled release drug delivery system
PL193282B1 (pl) 1997-01-14 2007-01-31 Lohmann Therapie Syst Lts System terapeutyczny do kontrolowanego uwalniania substancji czynnych w przewodzie żołądkowo-jelitowym
US5788987A (en) 1997-01-29 1998-08-04 Poli Industria Chimica Spa Methods for treating early morning pathologies
SE9702533D0 (sv) 1997-07-01 1997-07-01 Astra Ab New oral formulation
IN186245B (ru) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
US6350470B1 (en) * 1998-04-29 2002-02-26 Cima Labs Inc. Effervescent drug delivery system for oral administration
DE19822278A1 (de) 1998-05-18 1999-12-02 Lohmann Therapie Syst Lts Vorrichtung zur kontrollierten Freisetzung von Wirkstoff im Gastrointestinaltrakt mit verzögerter Pyloruspassage
FR2784583B1 (fr) 1998-10-16 2002-01-25 Synthelabo Composition pharmaceutique a residence gastrique et a liberation controlee
DE19850309A1 (de) 1998-10-30 2000-05-04 Lohmann Therapie Syst Lts Expandierbares gastroretensives Therapiesystem mit verlängerter Magenverweildauer
DK1146862T3 (da) * 1999-01-29 2003-07-21 Disphar Int Bv Farmaceutiske sammensætninger
AP2002002410A0 (en) * 1999-08-04 2002-03-31 Ranbaxy Laboratories Ltd Hydrodynamically Balancing Oral Drug Delivery System
FR2797185B1 (fr) 1999-08-06 2001-10-26 Galenix Dev Composition pharmaceutique flottante comprenant une phase active et une phase non active
US6352721B1 (en) * 2000-01-14 2002-03-05 Osmotica Corp. Combined diffusion/osmotic pumping drug delivery system
JP2004501190A (ja) 2000-06-23 2004-01-15 テバ　ファーマシューティカル　インダストリーズ　リミティド 治療薬の胃部保留および制御された放出のための急速膨張する組成物とその組成物を含む剤形
WO2003097018A1 (en) 2002-02-04 2003-11-27 Ranbaxy Laboratories Limited Hydrodynamically balancing oral drug delivery system with biphasic release
US20030008007A1 (en) 2001-04-23 2003-01-09 Jose Gutierrez-Rocca Release pharmaceutical construct for gastric retention
MXPA03012041A (es) * 2001-07-04 2004-03-26 Sun Pharmaceutical Ind Ltd Sistema de administracion controlada de farmacos de retencion gastrica.
US20030158154A1 (en) * 2001-07-17 2003-08-21 Moshe Fleshner-Barak Dosage forms for immediate gastric release of a calcium transport stimulator coupled with delayed gastric release of a bis-phosphonate
IN191024B (ru) * 2001-09-25 2003-09-13 J B Chemicals And Pharmaceutic
JP2003306428A (ja) 2002-04-17 2003-10-28 Zensei Yakuhin Kogyo Kk 服用性を改善した硬カプセル剤
WO2004032906A1 (en) 2002-10-11 2004-04-22 Depomed Development, Ltd. Gastro-retentive levodopa delivery form

Also Published As

Publication number Publication date
EP1732522A2 (en) 2006-12-20
ES2389729T3 (es) 2012-10-30
AU2005235239A1 (en) 2005-11-03
IL178054A (en) 2013-11-28
PE20061160A1 (es) 2006-11-12
NZ549853A (en) 2009-12-24
TW200533391A (en) 2005-10-16
US20080107732A1 (en) 2008-05-08
MA28542B1 (fr) 2007-04-03
BRPI0508744A (pt) 2007-08-14
KR101147666B1 (ko) 2012-05-22
CN1960711A (zh) 2007-05-09
WO2005101983A2 (en) 2005-11-03
MXPA06010678A (es) 2006-12-15
JP2007530530A (ja) 2007-11-01
AR048331A1 (es) 2006-04-19
PL1732522T3 (pl) 2012-12-31
AP2006003751A0 (en) 2006-10-31
MY148867A (en) 2013-06-14
AU2005235239B2 (en) 2011-06-23
WO2005101983A3 (en) 2006-04-27
CA2561109A1 (en) 2005-11-03
IL178054A0 (en) 2006-12-31
CA2561109C (en) 2012-09-18
EP1732522B1 (en) 2012-07-04
EA011151B1 (ru) 2009-02-27
KR20060126611A (ko) 2006-12-07
US9439851B2 (en) 2016-09-13
HK1094422A1 (en) 2007-03-30
JP5166018B2 (ja) 2013-03-21

Similar Documents

Publication Publication Date Title
EA200601771A1 (ru) Система, задерживающаяся в желудке
EP2311878A3 (en) Monoclonal antibodies against claudin-18 for treatment of cancer
EP4242236A3 (en) Monoclonal antibodies against claudin-18 for treatment of cancer
EA201100868A1 (ru) Противоопухолевые комбинации, содержащие антитела, специфически распознающие cd38, и цитарабин
WO2005123277A3 (en) Optical films and methods of making the same
WO2008017029A3 (en) Drug carriers, their synthesis, and methods of use thereof
EA201000784A1 (ru) Антагонисты пути hedgehog и их терапевтические применения
ITMI20032377A1 (it) Copolimeri del tfe.
NO20084004L (no) Monokolonne-FPSO
WO2009058694A3 (en) An implantable device having a slow dissolving polymer
FR2883179B1 (fr) Comprime enrobe
BR0317682A (pt) Composição farmacêutica de liberação modificada
DE60334379D1 (de) Copolymerverbindung, diese enthaltende polymerzusammensetzung, bilderzeugungsverfahren und dieselbe benutzende bilderzeugungsvorrichtung
WO2005101112A3 (en) Optical films and methods of making the same
WO2007061939A3 (en) Metabolite derivatives of the hdac inhibitor fk228
WO2007050294A3 (en) Liquid dosage forms having enteric properties of delayed and then sustained release
WO2008039659A3 (en) Corrosion resistant metallized films and methods of making the same
DK2014682T3 (da) Fremgangsmåde til fremstilling af pektin, og geleringsmiddel og gelatinøs fødevare under anvendelse deraf
EP1790336A4 (en) CAPSULE FILM COMPOSITION, CAPSULE FILM, AND CAPSULE COMPRISED THEREFROM
EA200600404A1 (ru) Пероральные препаративные формы кладрибина
WO2004062552A3 (en) Pharmaceutical composition containing a nsaid and a benzimidazole derivative
WO2003076472A3 (en) Neoplasm specific antibodies and uses thereof
FR2918664B1 (fr) Reactif pseudo peptidique trifonctionnel, ses utilisations et applications.
WO2004081027A3 (en) Neoplasm specific antibodies and uses thereof
WO2004010974A3 (en) Gelatin capsule exhibiting reduced cross-linking

Legal Events

Date Code Title Description
PC4A Registration of transfer of a eurasian patent by assignment
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU